Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Ag S/Adr (OP:BAYRY)

12.46 +0.10 (+0.81%)
Streaming Delayed Price Updated: 3:52 PM EST, Feb 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag S/Adr

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Bayer Snags Ex-Roche Exec Bill Anderson As New CEO; Shares Rocket ↗
Bill Anderson, who previously headed up Roche's pharma division, will take over June 1. 
Via Investor's Business Daily
News headline image
Investors Always Miss This Key Element ↗
Return on invested capital, or ROIC, is one of the most critical inputs needed to figure out the value of a company. 
Via Talk Markets
News headline image
Ring The Register; Plus, Where To Park Your Profits ↗
Sometimes an investment works out a lot quicker than expected. That’s the case with my July 2022 pick, Freeport-McMoRan Inc., the fourth-largest copper mining company in the world. 
Via Talk Markets
News headline image
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm ↗
 
Via Benzinga
News headline image
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories ↗
Reuters 
Via Benzinga
News headline image
Bayer: Aspirin To Crop Protection ↗
Pharmaceutical drugs account for 41% of Bayer's revenues and include Xarelto, Eylea, Mirena, Kogenate and Nexavar. Its OTC product lineup is filled with household names like Aleve, Alka Seltzer,... 
Via Talk Markets
News headline image
Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death ↗
 
Via Benzinga
News headline image
Bayer, Exscientia Part Ways On Artificial Intelligence Collaboration ↗
 
Via Benzinga
News headline image
Activist Investor Builds Stake In Bayer, Pushes Breakup ↗
Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up.  
Via Benzinga
News headline image
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down ↗
MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January. 
Via Benzinga
News headline image
Current Report: Bayer AG ↗
By my dogcatcher ideal, this may be a prime time to buy Bayer AG shares based on their dividends for the coming year 2022-23. 
Via Talk Markets
News headline image
Ionis Regains Rights To Thrombosis Candidate From Bayer ↗
 
Via Benzinga
News headline image
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher? ↗
It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus. 
Via InvestorPlace
News headline image
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug ↗
 
Via Benzinga
News headline image
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today? ↗
AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division. 
Via InvestorPlace
News headline image
Elon Musk Renews Twitter's Buyout Proposal, Apple Suppliers Working On Cutting China Reliance, E-Cigarette Maker Considers Bankruptcy: Top Stories Wednesday, Oct. 5 ↗
Wall Street Journal 
Via Benzinga
News headline image
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor ↗
Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup... 
Via Benzinga
News headline image
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More... ↗
Reuters 
Via Benzinga
News headline image
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report ↗
 
Via Benzinga
News headline image
BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors ↗
 
Via Benzinga
News headline image
Deere Invests Billions In Self-Driving Tractors, Smart Crop Sprayers: Report ↗
 
Via Benzinga
News headline image
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug ↗
 
Via Benzinga
News headline image
7 Stocks Under $15 to Buy and Hold Forever ↗
For patient investors who are willing to absorb potential turbulence, these are the stocks under $15 to buy for the long haul. 
Via InvestorPlace
News headline image
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops ↗
The companies hoped to reduce the risk of myriad complications for at-risk patients. 
Via Investor's Business Daily
News headline image
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence ↗
BioRestorative Therapies Inc. (NASDAQ: BRTX), a stem cell-focused biotech, says it wants to shift the paradigm of how doctors treat chronic pain in hopes of giving patients an option that’s effective,... 
Via Benzinga
News headline image
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today? ↗
DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site. 
Via InvestorPlace
News headline image
Science Wednesday: 'Silent Spring' At 60; Preserved Baby Mammoth Found In Yukon; Filling Medical Imaging, Nursing Shortages ↗
(This marks the first installment of Benzinga’s new weekly series Science Wednesday, which provides an overview of news and milestones within the sciences.) 
Via Benzinga
News headline image
BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products ↗
 
Via Benzinga
News headline image
SpringWorks Therapeutics Shares Jump On HC Wainwright Bullish Pitch ↗
HC Wainwright points out that investors are enthusiastic about SpringWorks Therapeutics Inc (NASDAQ: SWTX) nirogacestat clinical profile for desmoid tumors after the R&D day held last week. 
Via Benzinga
News headline image
7 Blue-Chip Stocks to Buy Now if You Have $250 to Spend ↗
These seven blue-chip stocks are trading at relative bargains and they can all be added to your portfolio for less than $250. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.